Lori Freedman insider trades: Organogenesis Holdings (ORGO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lori reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | ORGO | ↑ Buy | 252,264 | $2.88 | $725K | Direct | Jun 6, 2025 (0d) |
| Jun 17, 2014 | PSDV | ↓ Sell | 7,900 | $4.00 | $32K | Direct | Jun 18, 2014 (1d) |
| Jun 13, 2014 | PSDV | ↓ Sell | 11,700 | $4.02 | $47K | Direct | Jun 16, 2014 (3d) |
| May 5, 2014 | PSDV | ↓ Sell | 3,500 | $4.01 | $14K | Direct | May 7, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ORGO insiders
Open-market trades in the last 12 months
About Lori Freedman's insider trades
Lori Freedman is Chief Admin. and Legal Officer at Organogenesis Holdings (ORGO). Since May 5, 2014, Lori has reported 1 open-market purchase worth $725K and 3 sales worth $93K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (19 filings), shares withheld for taxes (10 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORGO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.